The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


Background: Hypertensive disorders during pregnancy are one of the main causes of maternal death worldwide. Hypertensive disorder during the period of pregnancy is a major cause of maternal death in lndia and also the rest of the world. Derangement of serum magnesium concentration in pregnant women may lead to develop preeclampsia. Therefore there may be a relationship between hypomagnesaemia and preeclampsia. Aim: This study was undertaken to assess serum Magnesium and Serum Inorganic Phosphate concentration in hypertensive and normotensive pregnant women in their 3rd trimester of pregnancy. Methods: The present study comprised of 100 cases of normotensive pregnant women and 100 cases of clinically established Hypertensive Pregnant women in their 3rd trimester. Serum Magnesium and Phosphate were estimated in Semi-auto analyzer from the study sample. Using Microsoft Excel software performed statistical analysis of the data. Results: Mean Magnesium concentration in hypertensive is 2±0.25 meq/l and in normotensive is 2.3±0.35 meq/l. The serum Magnesium concentration was found to be significantly lower (p<0.0001) in hypertensive study participants than in the normotensives participant. Conclusion: Magnesium can very well be used as biochemical markers of the new onset hypertensive pregnant women and also can be used in better management of established cases of eclampsia or preeclampsia patients.

Keywords

Magnesium, Phosphorus, Pre-Eclamsia, Eclamsia.
User
Notifications
Font Size